Aethlon Medical Inc. (AEMD)

Aethlon Medical stock forecast: buy or sell

Aethlon Medical stock outlook

  • Aethlon Medical stock collapsed -5.85% to close at $1.93 on the stock market today, after 3 consecutive sessions in negative.
  • Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.
No ad for you

Important note:
The thoughts published in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this report does not have any knowledge of the particular situations of the reader, his or her own finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are published for education motives only

Aethlon Medical stock chart overview

Should I buy Aethlon Medical stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is AEMD stock a buy?

In the current situation of Aethlon Medical there is not any eligible buy setup. This doesn't mean AEMD will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems

No ad for you

Should I sell Aethlon Medical stock?

Knowing when to sell a stock is even more difficult than knowing when to buy it. Trading strategies allow us to avoid impetuous decisions based on our moods or the buzz surrounding the market. When selling, as well as buying, our strategies are very simple to follow and are only valid for selling stocks in your porfolio, not for selling short Aethlon Medical stock

A golden rule is that you should never hold an operation that shows a greater losses than those expected by the time of the buy. The timing to sell shares should always be dictated by the stop-loss (automatic or manual)

Is it time to sell Aethlon Medical stock?

In the current situation of Aethlon Medical there is not any eligible sell setup, so Aethlon Medical stock holders with operations in profit can keep their positions

No ad for you

Analysts' recommendations to buy or sell Aethlon Medical stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

In the last month we couldn't find any rating for Aethlon Medical

No ad for you

Technical analysis

SMAs overview

Moving averages are tools for investors to detect momentum. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Usual time periods used for moving averages are 21 days, 50 days, 100 days and 200 days

Supports and resistances

Investors use support and resistance levels to spot price points in the stock price action that may work as barriers, preventing the price of shares to move in certain direction. Supports are levels where the price may stop as it falls. Price is more likely to "rebound" this level rather than break through it. Nevertheless, if the price breaks down the support, it will probably continue declining until finding another support level. On the other side, a resistance level is where the price tends to find opposition as it rises. In the same way, the price is more likely to "bounce off" at this level, and if it finally crosses this level, it will rally easily until it finds the next resistance

The current resistance levels are:

  • R1: $2.49 (29.02% above)
  • R2: $3.00 (55.44% above)
  • R3: $3.45 (78.76% above)
  • The current supports are:

  • S1: $1.75 (-9.33% below)
  • S2: $1.70 (-11.92% below)
  • S3: $1.19 (-38.34% below)
  • Bollinger bands

    This is an indicator that was introduced in the 1980s by John Bollinger. Basically, the Bollinger Bands are bands that run around a centralmoving average, varying the distance from the bottom to the top depending on market volatility. They are usually drawn by an interval of two standard deviations, above and below, from a moving average line. Bollinger himself recommends the moving average period to be 20

    Relative strength index

    The RSI (Relative Strength Index) is an oscillator-type indicator that gauges price movements to reveal when the share or financial asset is oversold or overbought. Like other oscillation indicators, the RSI moves from 0 to 100. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in 1978

    The RSI dropped below the overbought level of 70 in mid-June after just crossing to the overbough zone for a single day (weak signal). The RSI reading on Friday was 47.58. Aethlon Medical price dropped a 27.17% since RSI lost the overbought zone

    No ad for you

    Earnings and financials

    Aethlon Medical Inc. (AEMD) came out with quarterly earnings of $-0.22 per share, poorly missing the Wall St consensus estimate of $-0.16 per share. This quarterly report means an earnings surprise of -37.5%. Estimated turnover was $500,000 but Aethlon Medical slightly enhanced by 100%, reporting $0.00.

    In comparing, the EPS for the same quarter last year was $-1.35, so posted EPS is a increase of 83.7%. Turnover exploded a 176.33% on an annualized basis in the 2nd-quarter, from $748,120 to $2,067,290 last quarter.

    Aethlon Medical will host the earnings call next October. Estimated earnings of %s per-share for this quarter is $0.00. If you hold or you are planning to buy Aethlon Medical stock, be on your toes as financial reporting day usually has a higher than usual volatility, and price can soar and sink with exceptionally low liquidity and not respecting your buy/stop-loss orders. You can uncover more information about the earnings call and the earnings reports on the Investor Relations section of its website:

    No ad for you